Periodic Reporting for period 4 - PROGLUTASIS (Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis)

Cardiovascular diseases (CVD) are the leading cause of death worldwide with 17 million deaths every year and represent a major public health challenge. Limited pharmaceutical innovation, declining translational success and clinical failures mandate a detailed exploration of...